Skip to main content
  • Letter
  • Published:

Long live dynamic parameters!

In a recent article about pulse pressure variation (PPV), after 4 pages of physiologic explanations, Dr Sondergaard finally concluded that 'the subject is an exceptional demonstration of physiology but hardly guides the management of critically ill patients’ [1]. If I agree with the first part of this statement (I and others spent years dissecting the complex physiology behind PPV), I strongly disagree with the second part of the sentence for three reasons, which are not opinions but facts.

First, PPV and stroke volume variation (SVV) are increasingly used to guide fluid therapy both in the operating theater and in ICUs. This was confirmed by published peer-reviewed surveys, showing that the use of dynamic parameters increased from 1% in 1998 [2] to 45% in 2012 [3]. If dynamic parameters were not clinically useful one can doubt clinicians would have embraced this concept as they did.

Second, PPV and SVV are today displayed on almost all bedside and hemodynamic monitors, next to other vital signs such as the heart rate, blood pressure and arterial oxygen saturation. If medical device industry has financial interests in doing this, it is not fool enough to make research and development investments on something caregivers do not value in their clinical practice.

Third, at least 10 randomized controlled trials have demonstrated that hemodynamic strategies based on PPV or SVV monitoring allow a significant reduction in post-surgical complications and hospital length of stay (Table 1).

Table 1 Randomized controlled trials demonstrating the ability of hemodynamic strategies based on pulse pressure variation or stroke volume variation monitoring to improve postsurgical outcome

So dynamic parameters are well alive and useful for improving patient outcome. Long live dynamic parameters!

Abbreviations

PPV:

Pulse pressure variation

SVV:

Stroke volume variation.

References

  1. Sondergaard S: Pavane for a pulse pressure variation defunct. Crit Care 2013, 17: 327. 10.1186/cc13109

    Article  PubMed Central  PubMed  Google Scholar 

  2. Boldt J, Lenz M, Kumle B, Papsdorf M: Volume replacement strategies on intensive care units: results from a postal survey. Intensive Care Med 1998, 24: 147-151. 10.1007/s001340050536

    Article  CAS  PubMed  Google Scholar 

  3. Srinivasa S, Kahokehr A, Soop M, Taylor M, Hill AG: Goal-directed fluid therapy – a survey of anaesthetists in the UK, USA, Australia and New Zealand. BMC Anesthesiol 2013, 13: 5. 10.1186/1471-2253-13-5

    Article  PubMed Central  PubMed  Google Scholar 

  4. Benes J, Chytra I, Altmann P, Hluchy M, Kasal E, Svitak R, Pradl R, Stepan M: Intraoperative fluid optimization using stroke volume variation in high risk surgical patients: results of prospective randomized study. Crit Care 2010, 14: R118. 10.1186/cc9070

    Article  PubMed Central  PubMed  Google Scholar 

  5. Goepfert MS, Richter HP, Eulenburg CZ, Gruetzmacher J, Rafflenbeul E, Roeher K, Sandersleben AV, Diedrichs S, Reichenspurner H, Goetz AE, Reuter DA: Individually optimized hemodynamic therapy reduces complications and length of stay in the intensive care unit: a prospective, randomized controlled trial. Anesthesiology 2013, 119: 824-836. 10.1097/ALN.0b013e31829bd770

    Article  CAS  PubMed  Google Scholar 

  6. Lopes MR, Oliveira MA, Pereira V, Lemos I, Auler J, Michard F: Goal-directed fluid management based on pulse pressure variation monitoring during high-risk surgery: a pilot randomized controlled trial. Crit Care 2007, 11: R100. 10.1186/cc6117

    Article  PubMed Central  PubMed  Google Scholar 

  7. Mayer J, Boldt J, Mengistu A, Rohm K, Suttner S: Goal-directed intraoperative therapy based on autocalibrated arterial pressure waveform analysis reduces hospital stay in high-risk surgical patients: a randomized, controlled trial. Crit Care 2010, 14: R18. 10.1186/cc8875

    Article  PubMed Central  PubMed  Google Scholar 

  8. Ramsingh DS, Sanghvi C, Gamboa J, Cannesson M, Applegate RL: Outcome impact of goal directed fluid therapy during high risk abdominal surgery in low to moderate risk patients: a randomized controlled trial. J Clin Monit Comput 2013, 27: 249-257. 10.1007/s10877-012-9422-5

    Article  PubMed  Google Scholar 

  9. Salzwedel C, Puig J, Carstens A, Bein B, Molnar Z, Kiss K, Hussain A, Belda J, Kirov MY, Sakka SG, Reuter DA: Perioperative goal-directed hemodynamic therapy based on radial arterial pulse pressure variation and continuous cardiac index trending reduces postoperative complications after major abdominal surgery: a multi-center, prospective, randomized study. Crit Care 2013, 17: R191. 10.1186/cc12885

    Article  PubMed Central  PubMed  Google Scholar 

  10. Scheeren TWL, Wiesenack C, Gerlach H, Marx G: Goal-directed intraoperative fluid therapy guided by stroke volume and its variation in high-risk surgical patients: a prospective randomized multicentre study. J Clin Monit Comput 2013, 27: 225-233. 10.1007/s10877-013-9461-6

    Article  PubMed  Google Scholar 

  11. Zhang J, Qiao H, He Z, Wang Y, Che X, Liang W: Intraoperative fluid management in open gastrointestinal surgery: goal-directed versus restrictive. Clinics 2012, 67: 1149-1155. 10.6061/clinics/2012(10)06

    Article  PubMed Central  PubMed  Google Scholar 

  12. Zhang J, Chen CQ, Lei XZ, Feng ZY, Zhu SM: Goal-directed fluid optimization based on stroke volume variation and cardiac index during one-lung ventilation in patients undergoing thoracoscopy lobectomy operations: a pilot study. Clinics 2013, 68: 1065-1070. 10.6061/clinics/2013(07)27

    Article  PubMed Central  PubMed  Google Scholar 

  13. Zheng H, Guo H, Ye JR, Chen L, Ma HP: Goal-directed fluid therapy in gastrointestinal surgery in older coronary heart disease patients: randomized trial. World J Surg 2013, 37: 2820-2829. 10.1007/s00268-013-2203-6

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Frederic Michard.

Additional information

Competing interests

FM is a Vice-President, Global Medical Strategy, at Edwards Lifesciences. Of note, the above statements do not support the use of any specific medical device.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Michard, F. Long live dynamic parameters!. Crit Care 18, 413 (2014). https://doi.org/10.1186/cc13749

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/cc13749

Keywords